Medline Inc.

MDLNNASDAQHealthcare● Active

$33.19

$-0.43(-1.26%)

Market Cap$28.1B

P/E Ratio—

52W High$50.876

52W Low$32.815

Avg Volume9.4M

Open$33.52

Beta-0.24

Earnings Financials Revenue

Medline Inc. (MDLN) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

MDLN · earnings · updated Jun 8, 2026

Latest Earnings

Q2 FY2026Report Date: May 6, 2026

EPS Actual

$0.33

Est. $0.30 · +11.8%

Revenue

$7.35B

Est. $7.16B · +2.6%

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 6, 2026

After Market Close

▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak

MDLN reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Rev. $0.84B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

Rev. Est.$0.84B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Sep 2, 2026	$0.32	—	—	—	$7.52B	—
◌ Q3 FY2026	Aug 5, 2026	$0.32	—	—	—	$7.52B	—
▲ Q2 FY2026	May 6, 2026	$0.30	$0.33	+11.8%	$7.35B	$7.16B	+2.6%
▼ Q1 FY2026	Feb 25, 2026	$0.24	$0.22	-7.6%	$7.79B	$7.51B	+3.7%
— Q4 FY2025	Nov 4, 2025	—	$0.31	—	$7.12B	—	—

Q3 FY2026

Sep 2, 2026

EPS Actual

—

EPS Est.

$0.32

EPS Surpr.

—

Revenue

—

Q3 FY2026

Aug 5, 2026

EPS Actual

—

EPS Est.

$0.32

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 6, 2026Beat

EPS Actual

$0.33

EPS Est.

$0.30

EPS Surpr.

+11.8%

Revenue

$7.35B

Q1 FY2026

Feb 25, 2026Miss

EPS Actual

$0.22

EPS Est.

$0.24

EPS Surpr.

-7.6%

Revenue

$7.79B

Q4 FY2025

Nov 4, 2025

EPS Actual

$0.31

EPS Est.

—

EPS Surpr.

—

Revenue

$7.12B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2028	$0.58	$0.58	$0.59	7
Q3 FY2028	$0.47	$0.48	$0.48	12
Q2 FY2028	$0.42	$0.43	$0.43	7
Q1 FY2028	$0.40	$0.40	$0.41	7
Q4 FY2027	$0.50	$0.51	$0.51	6
Q3 FY2027	$0.42	$0.42	$0.42	7

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2028	$9.7B	$9.8B	$9.9B	6
Q3 FY2028	$8.8B	$8.9B	$8.9B	11
Q2 FY2028	$8.6B	$8.7B	$8.7B	6
Q1 FY2028	$8.5B	$8.6B	$8.6B	6
Q4 FY2027	$9.2B	$9.2B	$9.3B	7
Q3 FY2027	$8.3B	$8.4B	$8.4B	8

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q2 FY2026	May 6, 2026	+11.8%	$45.32	$42.01	-7.30%
▼ Q1 FY2026	Feb 25, 2026	-7.6%	$49.99	$48.18	-3.62%
— Q4 FY2025	Nov 4, 2025	—	No price data	$41.00	—

Q2 FY2026-7.30%

Report Date

May 6, 2026

EPS Beat/Miss

+11.8%

Price Before

$45.32

Price After

$42.01

Q1 FY2026-3.62%

Report Date

Feb 25, 2026

EPS Beat/Miss

-7.6%

Price Before

$49.99

Price After

$48.18

Q4 FY2025—

Report Date

Nov 4, 2025

EPS Beat/Miss

—

Price Before

—

Price After

$41.00

Avg Beat Reaction-7.30%

Avg Miss Reaction-3.62%

Beat Rate1 / 3 quarters

Largest Move-7.30% (Q2 FY2026)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Medline Inc. (MDLN) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.33 — beating the analyst consensus of $0.30 by +11.8%. The next MDLN earnings date is expected around September 1, 2026.

Each quarter, investors track MDLN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MDLN revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

MDLN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

MDLN earnings · 5 questions

Medline Inc.'s next earnings report is expected around September 1, 2026. MDLN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MDLN historically reports after market close (AMC).

MDLN earnings datewhen is MDLN earningsMDLN next earnings datewhen does MDLN report earningsMDLN earnings calendar

▸ Source: FMP · Medline Inc. SEC filings · US GAAP · Medline Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026